Literature DB >> 21204213

Angelman syndrome: Mutations influence features in early childhood.

Wen-Hann Tan1, Carlos A Bacino, Steven A Skinner, Irina Anselm, Rene Barbieri-Welge, Astrid Bauer-Carlin, Arthur L Beaudet, Terry Jo Bichell, Jennifer K Gentile, Daniel G Glaze, Lucia T Horowitz, Sanjeev V Kothare, Hye-Seung Lee, Mark P Nespeca, Sarika U Peters, Trilochan Sahoo, Dean Sarco, Susan E Waisbren, Lynne M Bird.   

Abstract

Angelman syndrome (AS) is a neurodevelopmental disorder caused by a lack of expression of the maternal copy of UBE3A. Although the "classic" features of AS are well described, few large-scale studies have delineated the clinical features in AS. We present baseline data from 92 children with a molecular diagnosis of AS between 5 and 60 months old who are enrolled in the National Institutes of Health Rare Diseases Clinical Research Network Angelman Syndrome Natural History Study from January 2006 to March 2008. Seventy-four percent of participants had deletions, 14% had either uniparental disomy (UPD) or imprinting defects, and 12% had UBE3A mutations. Participants with UPD/imprinting defects were heavier (P = 0.0002), while those with deletions were lighter, than the general population (P < 0.0001). Twenty out of 92 participants were underweight, all of whom had deletions or UBE3A mutations. Eight out of 92 participants (6/13 (46%) with UPD/imprinting defects and 2/11 (18%) with UBE3A mutations) were obese. Seventy-four out of 92 participants (80%) had absolute or relative microcephaly. No participant was macrocephalic. The most common behavioral findings were mouthing behavior (95%), short attention span (92%), ataxic or broad-based gait (88%), history of sleep difficulties (80%), and fascination with water (75%). Frequent, easily provoked laughter was observed in 60%. Clinical seizures were reported in 65% of participants but all electroencephalograms (EEGs) were abnormal. We conclude that the most characteristic feature of AS is the neurobehavioral phenotype, but specific EEG findings are highly sensitive for AS. Obesity is common among those with UPD/imprinting defects.
Copyright © 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21204213      PMCID: PMC3563320          DOI: 10.1002/ajmg.a.33775

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  44 in total

Review 1.  Angelman syndrome: mimicking conditions and phenotypes.

Authors:  C A Williams; A Lossie; D Driscoll
Journal:  Am J Med Genet       Date:  2001-06-01

2.  Angelman syndrome 2005: updated consensus for diagnostic criteria.

Authors:  Charles A Williams; Arthur L Beaudet; Jill Clayton-Smith; Joan H Knoll; Martin Kyllerman; Laura A Laan; R Ellen Magenis; Ann Moncla; Albert A Schinzel; Jane A Summers; Joseph Wagstaff
Journal:  Am J Med Genet A       Date:  2006-03-01       Impact factor: 2.802

3.  Angelman syndrome: clinical findings and follow-up data of 14 patients.

Authors:  Bülent Kara; Birsen Karaman; Meral Ozmen; Rasim Ozgür Rosti; Mine Calişkan; Hülya Kayserili; Seher Başaran
Journal:  Turk J Pediatr       Date:  2008 Mar-Apr       Impact factor: 0.552

4.  Clinical research on Angelman syndrome in the United Kingdom: observations on 82 affected individuals.

Authors:  J Clayton-Smith
Journal:  Am J Med Genet       Date:  1993-04-01

5.  Distinct phenotypes distinguish the molecular classes of Angelman syndrome.

Authors:  A C Lossie; M M Whitney; D Amidon; H J Dong; P Chen; D Theriaque; A Hutson; R D Nicholls; R T Zori; C A Williams; D J Driscoll
Journal:  J Med Genet       Date:  2001-12       Impact factor: 6.318

6.  Clinical, cytogenetic, and molecular diagnosis of Angelman syndrome: estimated prevalence rate in a Danish county.

Authors:  M B Petersen; K Brøndum-Nielsen; L K Hansen; K Wulff
Journal:  Am J Med Genet       Date:  1995-06-19

Review 7.  Molecular and clinical study of 61 Angelman syndrome patients.

Authors:  S Saitoh; N Harada; Y Jinno; K Hashimoto; K Imaizumi; Y Kuroki; Y Fukushima; T Sugimoto; M Renedo; J Wagstaff
Journal:  Am J Med Genet       Date:  1994-08-15

8.  Angelman syndrome: are the estimates too low?

Authors:  R H Buckley; N Dinno; P Weber
Journal:  Am J Med Genet       Date:  1998-12-04

Review 9.  Behavioral phenotypes in genetic syndromes: genetic clues to human behavior.

Authors:  Suzanne B Cassidy; Colleen A Morris
Journal:  Adv Pediatr       Date:  2002

10.  Behavior and neuropsychiatric manifestations in Angelman syndrome.

Authors:  Karine Pelc; Guy Cheron; Bernard Dan
Journal:  Neuropsychiatr Dis Treat       Date:  2008-06       Impact factor: 2.570

View more
  43 in total

Review 1.  Close yet so far away: a look into the management strategies of genetic imprinting disorders.

Authors:  Mark A Pianka; Alec T McIntosh; Sahaj D Patel; Pegah R Bakhshi; Mira Jung
Journal:  Am J Stem Cells       Date:  2018-10-01

2.  Ube3a imprinting impairs circadian robustness in Angelman syndrome models.

Authors:  Shu-qun Shi; Terry Jo Bichell; Rebecca A Ihrie; Carl Hirschie Johnson
Journal:  Curr Biol       Date:  2015-02-05       Impact factor: 10.834

Review 3.  Angelman Syndrome.

Authors:  Seth S Margolis; Gabrielle L Sell; Mark A Zbinden; Lynne M Bird
Journal:  Neurotherapeutics       Date:  2015-07       Impact factor: 7.620

4.  Seizure-like activity in a juvenile Angelman syndrome mouse model is attenuated by reducing Arc expression.

Authors:  Caleigh Mandel-Brehm; John Salogiannis; Sameer C Dhamne; Alexander Rotenberg; Michael E Greenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2015-04-06       Impact factor: 11.205

5.  Functional significance of atypical cortical organization in spina bifida myelomeningocele: relations of cortical thickness and gyrification with IQ and fine motor dexterity.

Authors:  Amery Treble; Jenifer Juranek; Karla K Stuebing; Maureen Dennis; Jack M Fletcher
Journal:  Cereb Cortex       Date:  2012-08-08       Impact factor: 5.357

6.  A mouse model of Angelman syndrome imprinting defects.

Authors:  Michael W Lewis; Dorianmarie Vargas-Franco; Deborah A Morse; James L Resnick
Journal:  Hum Mol Genet       Date:  2019-01-15       Impact factor: 6.150

7.  Eye gaze and pupillary response in Angelman syndrome.

Authors:  Michael P Hong; Janna L Guilfoyle; Lindsey N Mooney; Logan K Wink; Ernest V Pedapati; Rebecca C Shaffer; John A Sweeney; Craig A Erickson
Journal:  Res Dev Disabil       Date:  2017-07-24

8.  Network Analysis of UBE3A/E6AP-Associated Proteins Provides Connections to Several Distinct Cellular Processes.

Authors:  Gustavo Martínez-Noël; Katja Luck; Simone Kühnle; Alice Desbuleux; Patricia Szajner; Jeffrey T Galligan; Diana Rodriguez; Leon Zheng; Kathleen Boyland; Flavian Leclere; Quan Zhong; David E Hill; Marc Vidal; Peter M Howley
Journal:  J Mol Biol       Date:  2018-02-06       Impact factor: 5.469

Review 9.  Genetic control of postnatal human brain growth.

Authors:  Laura I van Dyck; Eric M Morrow
Journal:  Curr Opin Neurol       Date:  2017-02       Impact factor: 5.710

Review 10.  Age, plasticity, and homeostasis in childhood brain disorders.

Authors:  Maureen Dennis; Brenda J Spiegler; Jenifer J Juranek; Erin D Bigler; O Carter Snead; Jack M Fletcher
Journal:  Neurosci Biobehav Rev       Date:  2013-10-03       Impact factor: 8.989

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.